πŸ‡ΊπŸ‡Έ FDA
Patent

US 6509318

TGF-B inhibitors and methods

expired A61KA61K38/00A61P

Quick answer

US patent 6509318 (TGF-B inhibitors and methods) held by The Regents of the University of California expires Mon Jan 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jan 21 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K38/00, A61P, A61P17/02, A61P19/04